Newly published findings may lead to more personalized prostate cancer therapies. A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research in the United States. The findings may provide important information for identifying which patients potentially fare better when treated with a different therapy...
The contract is related to interaction characterization of therapeutic antibodies using Attana’s cell-based technology. The order value is approximately 300 kSEK and will have a positive effect of the cash flow and results during Q3 2018. Attana’s application specialists will perform interaction analysis assays....
Simplified, intuitive navigation, as well as enhanced visuals, quickly guide the visitor to detailed product, application and technical support information. In addition to technical specifications, product support resources include installation guides, technical papers, videos, and an on-demand webinar for simplifying selection, sizing and troubleshooting of rupture disks.
The recent installation of an Oxford Nanoimaging single molecule microscope at the Westmead Research Hub will provide researchers with much needed super resolution imaging capabilities. The microscope will allow researchers to observe cellular interactions at the nanoscale, giving them greater insights into how diseases such as cancer behave, increasing the chances of developing breakthrough cures...
BioTek Instruments, Inc., a leader in life science instrumentation, was issued a patent by the United States Patent and Trademark Office for its “User-Trained Autofocus” feature in their Gen5™ Microplate Reader and Imager Software, integrated with their advanced cell imaging systems. This autofocus method allows users to overcome imaging challenges arising from debris or dead cells, thick biology...
TTP plc (TTP), a leading independent technology and product development company, has completed and moved into a new extension of their life sciences development facility. The additional multi-disciplinary suite of lab space provides a Class II bio-handling and tissue culture laboratory and a dedicated facility for diagnostic system development under ISO 13485:2016. The new facilities are part of an ongoing investment at TTP in dedicated space for system development programmes for life science...
The way healthcare is delivered around the globe is changing. Patients are now at the centre of how medical care is delivered and recent advances in medical technology have allowed medical laboratory testing to move in parallel with this course. Keeping up-to-date with latest industry trends emerging from within the medical laboratory industry is critical to the lab professional, particularly in Europe...
New identity signals continued integration with VWR and ongoing commitment to customers. Following the acquisition of VWR in 2017, Avantor® introduced a new logo and visual identity today, signaling the company’s position as a leading global provider of products, services and solutions for professionals in the life sciences and advanced technology industries...
Weighing is the most commonly performed task in any laboratory. There are many types of balances that are being used for this purpose, they differ in capacities and readabilities but all of them are sensitive to harsh environment conditions. There are many factors that influence the weighing results. If the balance's location does not comply with the guidelines of good...
Supporting the innovation and application of high-performance liquid chromatography (HPLC) across novel and routine scientific applications, Thermo Fisher Scientific is showcasing its latest chromatography solutions, consumables and techniques at HPLC 2018 – The 47th International Symposium on High Performance Liquid Phase Separations and Related Techniques...
Gyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents. Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Cygnus Technologies, the leading assay and services provider for the detection and characterization...
High-precision analysis by the University of Natural Resources and Life Sciences, Vienna uncovers differences in recombinantly produced immunoglobulins; process also affects stability. Differences in production methods for therapeutic antibodies can lead to variations in their structure, depending on the recombinant procedure selected....
A plague of vampire horseflies bringing with them the threat of serious infection has illustrated why Britain must lead the race to develop new antibiotics – claims a charity. The hot weather has seen populations of bloodsucking clegs – or horseflies – reach Mediterranean levels. And with the female feeding off blood, Antibiotic Research UK (ANTRUK) has warned that bites could result...
FLIR Systems has announced a new guidebook for CBRNE professionals entitled '10 Things You Need to Know About Handheld Explosives Trace Detectors’. As the global threat of terrorism increases, security teams depend more than ever on proactive and preventative technologies. Handheld explosive trace detectors (ETDs) provide the portable screening capability needed to take the security mission mobile...
Heraeus is expanding its production capacities for Platinum-based Highly Potent Active Pharmaceutical Ingredients (Pt hAPIs). The expansion is Heraeus’ response to increasing global demands for these products in cancer treatment. Cancer cases are globally on the rise, causing an increasing demand for their treatment....
Incorrect capillary blood sampling is most common reason for inaccurate POC hemoglobin results. EKF Diagnostics, the global in vitro diagnostics company, has published an Educational Guide which provides a quick overview of capillary blood sampling best practice. It aims to help health care professionals understand common causes of pre-analytical errors and reduce their impact on hemoglobin results...
Evotec AG has announced that the strategic transaction signed on 15 June 2018, to integrate Sanofi's infectious disease unit including licensing-in the majority of Sanofi's infectious disease research portfolio, has been successfully closed with effect from 01 July 2018. This closing marks the completion of the required legal social process, initiated on....
Pittcon’s non-profit mission funds grants to colleges, high schools, elementary schools, researchers and more. Year after year, Pittcon distributes approximately $1 million towards its mission to sponsor and sustain educational and charitable activities for the advancement and benefit of scientific endeavor...
Validated tissue bank and pre-collected immuno-oncology datasets speed up investigative research projects through to clinical development. Bio-Techne has added new capabilities and options to its Advanced Cell Diagnostics (ACD)-branded RNAscope® and BaseScope™ in situ hybridization (ISH) Assay Services Portfolio to improve biotech and pharma discovery timelines and costs....
Customers to benefit from Sysmex’s extensive operational footprint. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it is now directly selling Cytocell Fluorescence In Situ Hybridisation (FISH) products through several established affiliates of Sysmex Corporation in Europe following its acquisition last year....
Funding will support development of a novel enzymatic process for DNA synthesis in collaboration with Durham University. EVONETIX LTD, the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, has announced that it had been awarded substantial funding to support the development of a novel enzymatic approach to DNA synthesis...
Deben, a leading provider of in-situ testing stages together with innovative accessories and components for electron microscopy, reports on how the University of Tsukuba team of Professor Jun-Ichi Fujita have developed a method to visualise local fields at relatively low beam voltages using the Deben ARM2-STEM detector. Jun-Ichi Fujita is a Professor in the Institute of Applied Physics at the University...
Newly published findings may lead to more personalized prostate cancer therapies. A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research in the United States. The findings may provide important information for identifying which patients potentially fare better when treated with a different therapy...
The contract is related to interaction characterization of therapeutic antibodies using Attana’s cell-based technology. The order value is approximately 300 kSEK and will have a positive effect of the cash flow and results during Q3 2018. Attana’s application specialists will perform interaction analysis assays....
Simplified, intuitive navigation, as well as enhanced visuals, quickly guide the visitor to detailed product, application and technical support information. 
The recent installation of an Oxford Nanoimaging single molecule microscope at the Westmead Research Hub will provide researchers with much needed super resolution imaging capabilities. The microscope will allow researchers to observe cellular interactions at the nanoscale, giving them greater insights into how diseases such as cancer behave, increasing the chances of developing breakthrough cures...
BioTek Instruments, Inc., a leader in life science instrumentation, was issued a patent by the United States Patent and Trademark Office for its “User-Trained Autofocus” feature in their Gen5™ Microplate Reader and Imager Software, integrated with their advanced cell imaging systems. This autofocus method allows users to overcome imaging challenges arising from debris or dead cells, thick biology...
TTP plc (TTP), a leading independent technology and product development company, has completed and moved into a new extension of their life sciences development facility. The additional multi-disciplinary suite of lab space provides a Class II bio-handling and tissue culture laboratory and a dedicated facility for diagnostic system development under ISO 13485:2016. The new facilities are part of an ongoing investment at TTP in dedicated space for system development programmes for life science...
The way healthcare is delivered around the globe is changing. Patients are now at the centre of how medical care is delivered and recent advances in medical technology have allowed medical laboratory testing to move in parallel with this course. Keeping up-to-date with latest industry trends emerging from within the medical laboratory industry is critical to the lab professional, particularly in Europe...
New identity signals continued integration with VWR and ongoing commitment to customers. Following the acquisition of VWR in 2017, Avantor® introduced a new logo and visual identity today, signaling the company’s position as a leading global provider of products, services and solutions for professionals in the life sciences and advanced technology industries...
Weighing is the most commonly performed task in any laboratory. There are many types of balances that are being used for this purpose, they differ in capacities and readabilities but all of them are sensitive to harsh environment conditions. There are many factors that influence the weighing results. If the balance's location does not comply with the guidelines of good...
Supporting the innovation and application of high-performance liquid chromatography (HPLC) across novel and routine scientific applications, Thermo Fisher Scientific is showcasing its latest chromatography solutions, consumables and techniques at HPLC 2018 – The 47th International Symposium on High Performance Liquid Phase Separations and Related Techniques...
Gyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents. Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Cygnus Technologies, the leading assay and services provider for the detection and characterization...
High-precision analysis by the University of Natural Resources and Life Sciences, Vienna uncovers differences in recombinantly produced immunoglobulins; process also affects stability. Differences in production methods for therapeutic antibodies can lead to variations in their structure, depending on the recombinant procedure selected....
A plague of vampire horseflies bringing with them the threat of serious infection has illustrated why Britain must lead the race to develop new antibiotics – claims a charity. The hot weather has seen populations of bloodsucking clegs – or horseflies – reach Mediterranean levels. And with the female feeding off blood, Antibiotic Research UK (ANTRUK) has warned that bites could result...
FLIR Systems has announced a new guidebook for CBRNE professionals entitled '10 Things You Need to Know About Handheld Explosives Trace Detectors’. As the global threat of terrorism increases, security teams depend more than ever on proactive and preventative technologies. Handheld explosive trace detectors (ETDs) provide the portable screening capability needed to take the security mission mobile...
Heraeus is expanding its production capacities for Platinum-based Highly Potent Active Pharmaceutical Ingredients (Pt hAPIs). The expansion is Heraeus’ response to increasing global demands for these products in cancer treatment. Cancer cases are globally on the rise, causing an increasing demand for their treatment....
Incorrect capillary blood sampling is most common reason for inaccurate POC hemoglobin results. 
Evotec AG has announced that the strategic transaction signed on 15 June 2018, to integrate Sanofi's infectious disease unit including licensing-in the majority of Sanofi's infectious disease research portfolio, has been successfully closed with effect from 01 July 2018. This closing marks the completion of the required legal social process, initiated on....
Pittcon’s non-profit mission funds grants to colleges, high schools, elementary schools, researchers and more. Year after year, Pittcon distributes approximately $1 million towards its mission to sponsor and sustain educational and charitable activities for the advancement and benefit of scientific endeavor...
Validated tissue bank and pre-collected immuno-oncology datasets speed up investigative research projects through to clinical development. 
Customers to benefit from Sysmex’s extensive operational footprint. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it is now directly selling Cytocell Fluorescence In Situ Hybridisation (FISH) products through several established affiliates of Sysmex Corporation in Europe following its acquisition last year....
Funding will support development of a novel enzymatic process for DNA synthesis in collaboration with Durham University. EVONETIX LTD, the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, has announced that it had been awarded substantial funding to support the development of a novel enzymatic approach to DNA synthesis...
Deben, a leading provider of in-situ testing stages together with innovative accessories and components for electron microscopy, reports on how the University of Tsukuba team of Professor Jun-Ichi Fujita have developed a method to visualise local fields at relatively low beam voltages using the Deben ARM2-STEM detector. Jun-Ichi Fujita is a Professor in the Institute of Applied Physics at the University...